Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 223,102 |
|
|||||
| News | - | ||||||
| Day High | 2.25 | Low High |
|||||
| Day Low | 2.00 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| NanoViricides Inc | NNVC | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.10 | -4.48% | 2.13 | 16:46:39 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.22 | 2.00 | 2.25 | 2.07 | 2.23 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,015 | 223,102 | $ 2.12 | $ 472,535 | - | 1.00 - 2.29 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:30:00 | 169 | $ 2.07 | USD |
NanoViricides Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 24.5M | 11.78M | - | 0 | -8.59M | -0.73 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
NanoViricides News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NNVC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.57 | 2.29 | 1.56 | 2.10 | 388,845 | 0.56 | 35.67% |
| 1 Month | 1.19 | 2.29 | 1.0297 | 1.83 | 249,884 | 0.94 | 78.99% |
| 3 Months | 1.27 | 2.29 | 1.0297 | 1.71 | 106,118 | 0.86 | 67.72% |
| 6 Months | 1.10 | 2.29 | 1.0001 | 1.54 | 70,640 | 1.03 | 93.64% |
| 1 Year | 1.0958 | 2.29 | 1.00 | 1.48 | 69,186 | 1.03 | 94.38% |
| 3 Years | 3.49 | 7.86 | 1.00 | 4.77 | 342,943 | -1.36 | -38.97% |
| 5 Years | 0.26 | 19.80 | 0.16045 | 7.10 | 686,705 | 1.87 | 719.23% |
NanoViricides Description
| Nanoviricides Inc is a nano-biopharmaceutical company which is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through an in-licensing strategy. |
